Short, unregulated hit pieces are getting some pharmaceutical executives worried:
These budding Michael Moores are a worry to the industry “because there are no internal controls on YouTube,” says Dorothy Wetzel, former consumer-marketing chief at Pfizer and now senior VP-management supervisor at Saatchi & Saatchi, New York, where she works on AstraZeneca accounts. “But,” she added, “you have to get used to it, because it’s here to stay.”
(via PharmaGossip)
Related posts:
- Bloodbath at Pfizer
- Fisticuffs between a doctor and drug rep
- "Pay to delay": How Big Pharma is paying off generic drug companies
- Desperate Pfizer going with ads to save failing Exubera
- Viagra OTC on Valentine’s Day
- Chantix: Pfizer’s golden goose?
- Death of the pharmaceutical sales rep
KevinMD.com on Facebook
 
Follow on Twitter  
Subscribe








Comments on this entry are closed.